Selenate inhibits adipogenesis through induction of transforming growth factor-β1 (TGF-β1) signaling

Biochemical and Biophysical Research Communications

Volumn 426, Issue 4, 2012, Pages 551-557

  Kim, Choon Young ^a   Kim, Gyo Nam ^a,b   Wiacek, Julie L ^a   Chen, Chih Yu ^a   Kim, Kee Hong ^a  

^a PURDUE UNIVERSITY   (United States)

^b Kyungnam University   (South Korea)

Author keywords

3T3 L1; Adipogenesis; Preadipocytes; Selenate; Selenium; TGF 1

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; ANTIBODY; INORGANIC SALT; METHYLSELENINIC ACID; SELENATE; SELENITE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADIPOGENESIS; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL ASSAY; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG INHIBITION; EX VIVO STUDY; FIBROBLAST; IMMUNOBLOTTING; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; SPINDLE CELL;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; MICE; SELENIUM COMPOUNDS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84867222181     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.08.125     Document Type: Article

References (36)

1. Spalding K.L., Arner E., Westermark P.O., Bernard S., Buchholz B.A., Bergmann O., Blomqvist L., Hoffstedt J., Naslund E., Britton T., Concha H., Hassan M., Ryden M., Frisen J., Arner P. Dynamics of fat cell turnover in humans. Nature 2008, 453:783-787.
2. Rosen E.D., MacDougald O.A. Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell Biol. 2006, 7:885-896.
3. Torti F.M., Torti S.V., Larrick J.W., Ringold G.M. Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor beta. J. Cell Biol. 1989, 108:1105-1113.
4. Choy L., Skillington J., Derynck R. Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation. J. Cell Biol. 2000, 149:667-682.
5. Shi Y., Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003, 113:685-700.
6. Wharton K., Derynck R. TGFbeta family signaling: novel insights in development and disease. Development 2009, 136:3691-3697.
7. Choy L., Derynck R. Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function. J. Biol. Chem. 2003, 278:9609-9619.
8. Yadav H., Quijano C., Kamaraju A.K., Gavrilova O., Malek R., Chen W., Zerfas P., Zhigang D., Wright E.C., Stuelten C., Sun P., Lonning S., Skarulis M., Sumner A.E., Finkel T., Rane S.G. Protection from obesity and diabetes by blockade of TGF-beta/Smad3 signaling. Cell Metab. 2011, 14:67-79.
9. Tan C.K., Leuenberger N., Tan M.J., Yan Y.W., Chen Y., Kambadur R., Wahli W., Tan N.S. Smad3 deficiency in mice protects against insulin resistance and obesity induced by a high-fat diet. Diabetes 2011, 60:464-476.
10. Battin E.E., Brumaghim J.L. Antioxidant activity of sulfur and selenium: a review of reactive oxygen species scavenging, glutathione peroxidase, and metal-binding antioxidant mechanisms. Cell Biochem. Biophys. 2009, 55:1-23.
11. Duntas L.H. Selenium and inflammation: underlying anti-inflammatory mechanisms. Horm. Metab. Res. 2009, 41:443-447.
12. Patrick L. Selenium biochemistry and cancer: a review of the literature. Altern. Med. Rev. 2004, 9:239-258.
13. Letavayova L., Vlckova V., Brozmanova J. Selenium: from cancer prevention to DNA damage. Toxicology 2006, 227:1-14.
14. Ramoutar R.R., Brumaghim J.L. Antioxidant and anticancer properties and mechanisms of inorganic selenium, oxo-sulfur, and oxo-selenium compounds. Cell Biochem. Biophys. 2010, 58:1-23.
15. Kim C.Y., Le T.T., Chen C., Cheng J.X., Kim K.H. Curcumin inhibits adipocyte differentiation through modulation of mitotic clonal expansion. J. Nutr. Biochem. 2011, 22:910-920.
16. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
17. Liu X., Lei M., Erikson R.L. Normal cells, but not cancer cells, survive severe Plk1 depletion. Mol. Cell. Biol. 2006, 26:2093-2108.
18. Kim J.H., Lee M.R., Jee M.K., Kang S.K. IFATS collection: selenium induces improvement of stem cell behaviors in human adipose-tissue stromal cells via SAPK/JNK and stemness acting signals. Stem Cells 2008, 26:2724-2734.
19. Lee H., Lee Y.J., Choi H., Ko E.H., Kim J.W. Reactive oxygen species facilitate adipocyte differentiation by accelerating mitotic clonal expansion. J. Biol. Chem. 2009, 16:10601-10609.
20. Ramoutar R.R., Brumaghim J.L. Effects of inorganic selenium compounds on oxidative DNA damage. J. Inorg. Biochem. 2007, 101:1028-1035.
21. Ranawat P., Bansal M.P. Decreased glutathione levels potentiate the apoptotic efficacy of selenium: possible involvement of p38 and JNK MAPKs - in vitro studies. Mol. Cell. Biochem. 2008, 309:21-32.
22. Ren Y., Huang F., Liu Y., Yang Y., Jiang Q., Xu C. Autophagy inhibition through PI3K/Akt increases apoptosis by sodium selenite in NB4 cells. BMB Rep. 2009, 42:599-604.
23. Wang Y., Zhao L., Smas C., Sul H.S. Pref-1 interacts with fibronectin to inhibit adipocyte differentiation. Mol. Cell. Biol. 2010, 30:3480-3492.
24. Pinto A., Speckmann B., Heisler M., Sies H., Steinbrenner H. Delaying of insulin signal transduction in skeletal muscle cells by selenium compounds. J. Inorg. Biochem. 2011, 105:812-820.
25. Meltzer H.M., Norheim G., Loken E.B., Holm H. Supplementation with wheat selenium induces a dose-dependent response in serum and urine of a Se-replete population. Br. J. Nutr. 1992, 67:287-294.
26. Goodman M., Bostick R.M., Kucuk O., Jones D.P. Clinical trials of antioxidants as cancer prevention agents: past, present, and future. Free Radic. Biol. Med. 2011, 51:1068-1084.
27. Ledesma M.C., Jung-Hynes B., Schmit T.L., Kumar R., Mukhtar H., Ahmad N. Selenium and vitamin E for prostate cancer: post-SELECT (Selenium and Vitamin E Cancer Prevention Trial) status. Mol. Med. 2010, 17:134-143.
28. Stranges S., Marshall J.R., Natarajan R., Donahue R.P., Trevisan M., Combs G.F., Cappuccio F.P., Ceriello A., Reid M.E. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann. Intern. Med. 2007, 147:217-223.
29. Steinbrenner H., Speckmann B., Pinto A., Sies H. High selenium intake and increased diabetes risk: experimental evidence for interplay between selenium and carbohydrate metabolism. J. Clin. Biochem. Nutr. 2011, 48:40-45.
30. Akbaraly T.N., Arnaud J., Rayman M.P., Hininger-Favier I., Roussel A.M., Berr C., Fontbonne A. Plasma selenium and risk of dysglycemia in an elderly French population: results from the prospective Epidemiology of Vascular Ageing Study. Nutr. Metab. (Lond.) 2010, 7:21.
31. Hester R.L., Curry E., Bower J. The determination of hemodialysis blood recirculation using blood urea nitrogen measurements. Am. J. Kidney Dis. 1992, 20:598-602.
32. Muller A.S., Most E., Pallauf J. Effects of a supranutritional dose of selenate compared with selenite on insulin sensitivity in type II diabetic dbdb mice. J. Anim. Physiol. Anim. Nutr. (Berl.) 2005, 89:94-104.
33. van Eersel J., Ke Y.D., Liu X., Delerue F., Kril J.J., Gotz J., Ittner L.M. Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models. Proc. Natl. Acad. Sci. USA 2010, 107:13888-13893.
34. Gagnon A.M., Chabot J., Pardasani D., Sorisky A. Extracellular matrix induced by TGFbeta impairs insulin signal transduction in 3T3-L1 preadipose cells. J. Cell Physiol. 1998, 175:370-378.
35. Samad F., Yamamoto K., Pandey M., Loskutoff D.J. Elevated expression of transforming growth factor-beta in adipose tissue from obese mice. Mol. Med. 1997, 3:37-48.
36. Fain J.N., Tichansky D.S., Madan A.K. Transforming growth factor beta1 release by human adipose tissue is enhanced in obesity. Metabolism 2005, 54:1546-1551.